From evidence-based medicine to marketing-based medicine: Evidence from internal industry documents [Book Review]
David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Journal of Bioethical Inquiry 7 (1):13-29 (2010)
While much excitement has been generated surrounding evidence-based medicine, internal documents from the pharmaceutical industry suggest that the publicly available evidence base may not accurately represent the underlying data regarding its products. The industry and its associated medical communication firms state that publications in the medical literature primarily serve marketing interests. Suppression and spinning of negative data and ghostwriting have emerged as tools to help manage medical journal publications to best suit product sales, while disease mongering and market segmentation of physicians are also used to efficiently maximize profits. We propose that while evidence-based medicine is a noble ideal, marketing-based medicine is the current reality.
|Keywords||Evidence-based medicine Marketing Marketing-based medicine Pharmaceutical industry Olanzapine Quetiapine|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
Barton Moffatt & Carl Elliott (2007). Ghost Marketing: Pharmaceutical Companies and Ghostwritten Journal Articles. Perspectives in Biology and Medicine 50 (1):18-31.
Sergio Sismondo, Ghost Management: How Much of the Medical Literature is Shaped Behind the Scenes by the Pharmaceutical Industry?
Citations of this work BETA
Adam Jacobs (2010). Letter to the Editor. Journal of Bioethical Inquiry 7 (3):287-287.
Melody J. Slashinski, Sheryl A. McCurdy, Laura S. Achenbaum, Simon N. Whitney & Amy L. McGuire (2012). “Snake-Oil,” “Quack Medicine,” and “Industrially Cultured Organisms:” Biovalue and the Commercialization of Human Microbiome Research. [REVIEW] BMC Medical Ethics 13 (1):28-.
Similar books and articles
Hillel D. Braude (2009). Clinical Intuition Versus Statistics: Different Modes of Tacit Knowledge in Clinical Epidemiology and Evidence-Based Medicine. Theoretical Medicine and Bioethics 30 (3):181-198.
Maya J. Goldenberg (2010). Clinical Evidence and the Absent Body in Medical Phenomenology. International Journal of Feminist Approaches to Bioethiics 3 (1):43-71.
Erica Zarkovich & R. E. G. Upshur (2002). The Virtues of Evidence. Theoretical Medicine and Bioethics 23 (4-5):403-412.
Simon A. Cole, Toward Evidence-Based Evidence: Supporting Forensic Knowledge Claims in the Post-Daubert Era.
Maya J. Goldenberg (2009). Iconoclast or Creed? Objectivism, Pragmatism, and the Hierarchy of Evidence. Perspectives in Biology and Medicine 52 (2):168-187.
Peter C. Gøtzsche (2007). Rational Diagnosis and Treatment: Evidence-Based Clinical Decision-Making. J. Wiley.
Wendy A. Rogers (2002). Is There a Tension Between Doctors' Duty of Care and Evidence-Based Medicine? Health Care Analysis 10 (3):277-287.
Brian Hazelton Walsh (2010). The Spatialisation of Disease: Foucualt and Evidence-Based Medicine (Ebm). [REVIEW] Journal of Bioethical Inquiry 7 (1):31-42.
Maya J. Goldenberg (2006). On Evidence and Evidence-Based Medicine: Lessons From the Philosophy of Science. Social Science and Medicine 62 (11):2621-2632.
Added to index2010-01-27
Total downloads108 ( #9,944 of 1,102,758 )
Recent downloads (6 months)6 ( #46,777 of 1,102,758 )
How can I increase my downloads?